The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
- 1 October 1996
- journal article
- Published by Elsevier in Brain Research
- Vol. 735 (2) , 208-216
- https://doi.org/10.1016/0006-8993(96)00587-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reduction in firing rate of substantia nigra pars reticulata neurons by valproate: influence of different types of anesthesia in ratsBrain Research, 1995
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- ucb L059, a novel anti-convulsant drug: pharmacological profile in animaisEuropean Journal of Pharmacology, 1992
- Use of Inhibitors of γ‐Aminobutyric Acid (GABA) Transaminase for the Estimation of GABA Turnover in Various Brain Regions of Rats: A Reevaluation of Aminooxyacetic AcidJournal of Neurochemistry, 1989
- Progression and Generalization of Seizure Discharge: Anatomical and Neurochemical SubstratesEpilepsia, 1988
- Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implicationsMolecular and Cellular Biochemistry, 1981
- Heavy metal intensification of DAB-based HRP reaction product.Journal of Histochemistry & Cytochemistry, 1981
- Effect of Inhibitors of GABA Transaminase on the Synthesis, Binding, Uptake and Metabolism of GABAJournal of Neurochemistry, 1980
- Antidromic identification of dopaminergic and other output neurons of the rat substantia nigraBrain Research, 1978